Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.04. | Movano files to sell 78.03M shares of common stock for holders | 1 | Seeking Alpha | ||
16.04. | Movano Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
11.04. | Earnings call: Movano Health reports on Evie Ring success and future plans | 1 | Investing.com | ||
05.04. | Movano Jumps on Word of Private Placement | 2 | Baystreet.ca | ||
04.04. | Movano GAAP EPS of -$0.11 | 2 | Seeking Alpha | ||
04.04. | Movano Health Reports 2023 Financial Results and Provides Business Update | 67 | PR Newswire | Executes $24 million funding extending cash runway Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities Plans launch of Evie Med Conference Call at 2:00 PM PT / 5:00 PM ET... ► Artikel lesen | |
03.04. | Movano Inc. - 8-K, Current Report | 1 | SEC Filings | ||
02.04. | Movano Health announces $24M private placement | 2 | Seeking Alpha | ||
02.04. | Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company | 43 | PR Newswire | The seed investment and agreement underscores Movano Health's multi-analyte and proprietary mmWave radio frequency technology
PLEASANTON, Calif., April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq:... ► Artikel lesen | |
01.04. | Movano Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
15.03. | Movano Health Says Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines In Hypoxia Trial | 1 | RTTNews | ||
09.01. | Movano Health und ams Osram: Wearable-Ring Evie punktet auf der CES | 33 | elektroniknet | ||
09.01. | Movano Health and ams OSRAM join hands for women's lifestyle monitoring solutions | 19 | Seeking Alpha | ||
09.01. | Movano's smart ring is the rare CES health gadget that will actually ship | 1 | The Verge | ||
09.01. | Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women | 551 | PR Newswire | LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, and ams OSRAM, a leader in technology for biometric monitoring, have collaborated to include ams... ► Artikel lesen | |
29.11.23 | Movano Inc. - 8-K, Current Report | 1 | SEC Filings | ||
16.11.23 | Movano director discloses purchase of 295K shares | 2 | Seeking Alpha | ||
16.11.23 | Movano Inc. (MOVE) Q3 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
15.11.23 | Movano GAAP EPS of -$0.18 | 1 | Seeking Alpha | ||
15.11.23 | Movano Health prices $3.6 million public offering | 1 | Seeking Alpha |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ORPEA | 13,954 | +4,48 % | ORPEA S.A.: Filing of the 2023 Universal Registration Document | Regulatory News:
ORPEA S.A. (the "Company") (Paris:ORP) filed, today, its 2023 Universal Registration Document (document d'enregistrement universel) with the French Autorité des Marchés Financiers... ► Artikel lesen | |
NANO-X IMAGING | 9,400 | +0,59 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
BUTTERFLY NETWORK | 0,999 | +5,75 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
GOODRX | 7,410 | +4,22 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
JOINT CORP | 15,910 | -1,30 % | Joint Corp reports results for the quarter ended in March - Earnings Summary | ||
CARMAT | 3,640 | +18,37 % | CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook | EFICAS study reaches the milestone of 20 implants
Interim study results above expectations
Confirmation of short-term financial support from several key shareholders
Regulatory... ► Artikel lesen | |
HYPERFINE | 0,830 | +3,75 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
BIOMERICA | 0,595 | +6,25 % | Biomerica jumps on signing multi-year distribution deal with major UAE healthcare company | ||
MIMEDX | 7,135 | -4,87 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen | |
ATRION | 384,00 | 0,00 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
ATRICURE | 22,170 | +6,13 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
TALKSPACE | 3,215 | +1,42 % | Talkspace Q1 Earnings Preview | ||
OUTSET MEDICAL | 3,850 | +22,61 % | US STOCKS NAPCO Security Technologies, Outset Medical, US energy sector | ||
CASTLE BIOSCIENCES | 24,450 | +0,49 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen |